fomesafen has been researched along with vortioxetine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bang-Andersen, B; Boyle, NJ; Brennum, LT; Bundgaard, C; Fischer, CW; Hogg, S; Lassen, AB; Liebenberg, N; Miller, S; Mørk, A; Nielsen, SM; Pehrson, A; Sánchez, C; Stensbøl, TB; Wegener, G; Westrich, L; Zhong, H | 1 |
1 other study(ies) available for fomesafen and vortioxetine
| Article | Year |
|---|---|
Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder.
Topics: Animals; Anti-Anxiety Agents; Biogenic Monoamines; Citalopram; Depressive Disorder, Major; Humans; Male; Ondansetron; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Reflex; Serotonin Plasma Membrane Transport Proteins; Sulfides; Vocalization, Animal; Vortioxetine | 2012 |